Predictors of Primary Ceaseran Section At Women Health Hospital

December 26, 2024 updated by: Mina Mikhail labib melk, Assiut University
Predictors of primary Ceaseran section Highlight the most important preventable risk factors that may help decrease rate of ceaseran section in Egypt

Study Overview

Detailed Description

A caesarean section is a surgical procedure in which incisions are made through a woman's Anterior abdominal and uterus to deliver the baby. (1) It is performed whenever abnormal conditions are making normal delivery difficult and endangering the life of the mother or the baby. Cesarean section is the most common obstetric surgical procedure worldwide. Although low cesarean delivery rates are associated with an increase in adverse events, higher-than-institution cesarean delivery rates have been shown not to improve maternal or neonatal outcomes but to cause additional costs and unnecessary interventions (2). There is a global concern that the number of cesarean deliveries is increasing worldwide, regardless of health status, age, race, or gestational age. (3) A Cesarean section of can only effectively save the life of mother and child when it is medically justified (4). For mothers or infants who do not require a Cesarean section, there is no advantage to having it. (5) Recently, it has been reported that the rate of cesarean delivery in Egypt is increasing. (6) All women undergoing indicated or voluntary Cesarean section are at risk of various complications and negative consequences for future pregnancies.(7) Therefore, avoiding unnecessary Cesarean section must be a top priority.(8) An increase in Cesarean has been observed to be among women of all ages and race/ethnicities, in every state, and is thought to be due to; decrease in Vaginal Births after Caesarean Section (VBAC), decreased vaginal births of breech presentation, and increased prevalence of high-risk pregnancies such as advanced maternal age and some subjective indications during labour such as non-reassuring fetal status and arrest of dilation

Study Type

Observational

Enrollment (Estimated)

298

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study will be conducted at Women's Health Hospital in Assiut University, Department of Obstetrics and Gynecology.

divided into 2 groups :females had primary ceaseran section for case and primary vaginal delivery for control group

Description

a. Inclusion criteria:

  1. All pregnant women underwent primary ceaseran section
  2. All primiparous women delivered vaginally b. Exclusion criteria:

(1) any women done previous one or more ceaseran section before (2) All pregnant women delivered vaginally before more than one time (2) women had previous uterine scar as hysterectomy, myomectomy (4) any female refused to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Primary ceaseran section women
A comparison between primary ceaseran section women and primary vaginally delivery women to determine predictors of primary ceaseran section
A comparison between primary ceaseran section women and primary vaginally delivery women to determine predictors of primary ceaseran section
Primary vaginally delivery women
A comparison between primary ceaseran section women and primary vaginally delivery women to determine predictors of primary ceaseran section
A comparison between primary ceaseran section women and primary vaginally delivery women to determine predictors of primary ceaseran section

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Identify the risk factors of primary ceaseran section
Time Frame: Baseline
Identify the risk factors of primary ceaseran section and it's predictors among women seeking delivery care in women health hospital
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Highlight the most important preventable factors of ceaseran section
Time Frame: Baseline
Highlight the most important preventable factors that may help decrease rate of ceaseran section in Egypt
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 30, 2024

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

December 30, 2027

Study Registration Dates

First Submitted

December 26, 2024

First Submitted That Met QC Criteria

December 26, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 26, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • Predictors of ceaseran section

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe